| Book
4: Worker safety |
 |
All research
protocols involving genetic manipulation should be considered
by Research Ethics Committees and safety committees. Biosafety10
is chiefly concerned with the biohazards that may result from
manipulating harmful organisms. After thorough risk analysis,
all relevant protocols should be designed to reduce hazards
to laboratory workers and the environment. Workers must be adequately
trained before embarking on any work, and the necessary containment
facilities and equipment must be installed before permission
will be granted in respect of the relevant biosafety levels
of experiments.
It is the
duty of the host institution to ensure that adequate facilities
are present and that control is exercised over the researchers
and workers who are to be involved. The host institution should
have a committee, which may be a Research Ethics Committee,
concerned with biosafety and containment, but not necessarily
limited to such considerations. All relevant experiments to
be conducted in the institution must be approved by this authority,
which will be responsible for monitoring the procedures in the
host institution.
Book
4: Risk assessment
Risk assessment
is the activity concerned with the decision to approve activities
associated with a biohazard. Apart from biohazards associated
with any given organism, additional factors need to be considered.
These may include, but not be limited to, the following:
-
the concentration and quantity (number) of organisms concerned;
- the
stability and viability of the organism;
- the
potential for transmission, whether by contact or aerosol;
- the
nature of the work envisaged (whether liquid culture or aerosol
challenge);
- specific
risks associated with GMOs (genetically modified organisms);
- risk
of by-products, such as spores, toxins, virulence factors;
- risk
of unknown contaminants such as cells or cell lines with latent
oncogenic viruses or other associated viruses.
Some considerations
are listed below.
4.1
Prokaryotes (including microbes, viruses)
There is a wealth of knowledge concerning the pathogenic potential
of most microbes and viruses. This information is readily available,
even at textbook level.
4.2
Eukaryotes
-
Parasites: There is a considerable body of information concerning
most parasites. There may be different risks associated with
parasites, depending on whether the project involves in vivo
work (animal model) or in vitro (cultured) organisms. Furthermore,
the risk may differ according to the stage of development.
The host range is a further consideration for risk assessment.
- Intact
organisms: These may be pathogenic, such as protozoans, or
they may pose handling risks in general, like venomous animals.
Alternatively, the closer the organism is to humans phylogenetically,
the greater the potential risk from zoonoses (see also (c)
and (d) below).
- Cells,
cell lines or body fluids: Tissue samples or body fluids present
high risks and should be treated with extreme care. The risk
originates not from the cells themselves, but from their potential
to harbour pathogenic organisms or agents, including prions.
The risk is assessed at the level of the agent of highest
possible risk. (d) Cultured material: There is a risk that
cultured cells or tissue samples may contain pathogens, as
in (b) and (c) above.
|